EAST RUTHERFORD, N.J., Oct. 31, 2012 /PRNewswire/ -- Due to complications from the storm affecting the East Coast, Cambrex Corporation (NYSE: CBM, "Cambrex") will now report its results of the third quarter ended September 30, 2012 after the market closes Monday, November 5, 2012
The Company will also host a conference call to discuss the financial results Monday, November 5, 2012 at 4:45 p.m. EST.
Third Quarter 2012 Earnings Conference Call
Monday, November 5, 2012 at 4:45 p.m. Eastern Time
1-888-430-8705 for U.S.
1-719-325-2455 for International
1-888-203-1112 for U.S.
1-719-457-0820 for International
Available through Monday, November 12, 2012
Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics. We offer Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Our development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage form products. For more information, please visit www.cambrex.com.
SOURCE Cambrex Corporation